Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Other financing activities: 2020-2024

Historic Other financing activities for Kura Oncology (KURA) over the last 5 years, with Dec 2024 value amounting to $8.6 million.

  • Kura Oncology's Other financing activities fell 83.06% to $515,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $8.6 million for FY2024, which is 613.43% up from last year.
  • According to the latest figures from FY2024, Kura Oncology's Other financing activities is $8.6 million, which was up 613.43% from $1.2 million recorded in FY2023.
  • Kura Oncology's 5-year Other financing activities high stood at $10.2 million for FY2020, and its period low was $1.2 million during FY2023.
  • Moreover, its 3-year median value for Other financing activities was $4.4 million (2022), whereas its average is $4.7 million.
  • As far as peak fluctuations go, Kura Oncology's Other financing activities crashed by 72.71% in 2023, and later skyrocketed by 613.43% in 2024.
  • Yearly analysis of 5 years shows Kura Oncology's Other financing activities stood at $10.2 million in 2020, then tumbled by 56.82% to $4.4 million in 2021, then fell by 0.16% to $4.4 million in 2022, then slumped by 72.71% to $1.2 million in 2023, then spiked by 613.43% to $8.6 million in 2024.